Anti-SCUB3/ SCUBE3/ CEGF3 monoclonal antibody
Anti-SCUB3/ SCUBE3/ CEGF3 antibody for FACS & in-vivo assay
Go to SCUBE3/SCUBE3 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)
Product information
Catalog No. | Product Name | Species Reactivity |
---|---|---|
GM-Tg-hg-MP2319-Ab-1/ GM-Tg-hg-MP2319-Ab-2 | Anti-Human SCUBE3 monoclonal antibody | Human |
GM-Tg-rg-MP2319-Ab-1/ GM-Tg-rg-MP2319-Ab-2 | Anti-Rat SCUBE3 monoclonal antibody | Rat |
GM-Tg-mg-MP2319-Ab-1/ GM-Tg-mg-MP2319-Ab-2 | Anti-Mouse SCUBE3 monoclonal antibody | Mouse |
GM-Tg-cynog-MP2319-Ab-1/ GM-Tg-cynog-MP2319-Ab-2 | Anti-Cynomolgus/ Rhesus macaque SCUBE3 monoclonal antibody | Cynomolgus/ Rhesus macaque |
GM-Tg-felg-MP2319-Ab-1/ GM-Tg-felg-MP2319-Ab-2 | Anti-Feline SCUBE3 monoclonal antibody | Feline |
GM-Tg-cang-MP2319-Ab-1/ GM-Tg-cang-MP2319-Ab-2 | Anti-Canine SCUBE3 monoclonal antibody | Canine |
GM-Tg-bovg-MP2319-Ab-1/ GM-Tg-bovg-MP2319-Ab-2 | Anti-Bovine SCUBE3 monoclonal antibody | Bovine |
GM-Tg-equg-MP2319-Ab-1/ GM-Tg-equg-MP2319-Ab-2 | Anti-Equine SCUBE3 monoclonal antibody | Equine |
Size: 1mg | 10mg | 100mg
Product Description
Catalog No. | GM-Tg-hg-MP2319-Ab-1/ GM-Tg-hg-MP2319-Ab-2; GM-Tg-rg-MP2319-Ab-1/ GM-Tg-rg-MP2319-Ab-2; GM-Tg-mg-MP2319-Ab-1/ GM-Tg-mg-MP2319-Ab-2; GM-Tg-cynog-MP2319-Ab-1/ GM-Tg-cynog-MP2319-Ab-2; GM-Tg-felg-MP2319-Ab-1/ GM-Tg-felg-MP2319-Ab-2; GM-Tg-cang-MP2319-Ab-1/ GM-Tg-cang-MP2319-Ab-2; GM-Tg-bovg-MP2319-Ab-1/ GM-Tg-bovg-MP2319-Ab-2; GM-Tg-equg-MP2319-Ab-1/ GM-Tg-equg-MP2319-Ab-2 |
Products Name | Anti-SCUBE3 monoclonal antibody |
Format | mab |
Target Name | SCUBE3 |
Protein Sub-location | Transmembrane Protein |
Category of antibody | FACS/Biofunctional Antibody |
Derivation (species) | Mouse |
CH1+2+3 Isotype (Receptor identification) | IgG |
Type of Light Chain (VD-LC) | N/A |
Expression platform | Mammalian Expression |
Bioactivity validation | Binding affinity is validated by using flow cytometry with antigen overexpressed cell line. The biofunction of antibodies are validated in cell-based assay (IC50 or EC50 TBD). |
Tag | Fc |
Products description | Pre-made anti-SCUBE3 benchmark inhibitory monoclonal antibody(mab) (blocking antibody inhibitor) is expressed by mammalian cell line as a benchmark antibody for cell culture, FACS,ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) |
Purity | Purity: ≥95% (SDS-PAGE) |
Application | Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research. |
Formulation & Reconstitution | Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4); For PSB2, reconstituted with 0.9% sodium chloride; For PBS, reconstituted with ddH2O. |
Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
Reference
Data / case study
Click to get more Data / Case study about the product.
Associated products
Category | Cat No. | Products Name |
Target Antigen | Products Developing | Multi-species SCUB3/ SCUBE3/ CEGF3 VLP (virus-like particle) (Products Developing) |
Target information
Target ID | GM-MP2319 |
Target Name | SCUBE3 |
Gene ID | 222663,268935,294297,718726,481753,101097643,100300124,100629959 |
Gene Symbol and Synonyms | CEGF3,D030038I21Rik,SCUBE3,SSFSC2 |
Uniprot Accession | Q8IX30 |
Uniprot Entry Name | SCUB3_HUMAN |
Protein Sub-location | Transmembrane Protein |
Category | |
Disease | N/A |
Gene Ensembl | ENSG00000146197 |
Target Classification | N/A |
The target: SCUBE3, gene name: SCUBE3, also named as CEGF3. This gene encodes a member of the signal peptide, complement subcomponents C1r/C1s, Uegf, bone morphogenetic protein-1 and epidermal growth factor-like domain containing protein family. Overexpression of this gene in human embryonic kidney cells results in secretion of a glycosylated form of the protein that forms oligomers and tethers to the cell surface. This gene is upregulated in lung cancer tumor tissue compared to healthy tissue and is associated with loss of the epithelial marker E-cadherin and with increased expression of vimentin, a mesenchymal marker. In addition, the protein encoded by this gene is a transforming growth factor beta receptor ligand, and when secreted by cancer cells, it can be cleaved in vitro to release the N-terminal epidermal growth factor-like repeat domain and the C-terminal complement subcomponents C1r/C1s domain. Both the full length protein and C-terminal fragment can bind to the transforming growth factor beta type II receptor to promote the epithelial-mesenchymal transition and tumor angiogenesis. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Dec 2014].
About Gmab
GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.
Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.